Prognostic properties of the baseline prostate-specific antigen value-insights from the European randomized study of screening for prostate cancer

被引：0
|
作者：
Scherer, Thomas Paul [1 ]
Poyet, Cedric [1 ,2 ]
机构：
[1] Univ Zurich, Univ Hosp Zurich, Dept Urol, Zurich, Switzerland
[2] Univ Hosp Zurich, Dept Urol, Ramistr 100, CH-8091 Zurich, Switzerland
来源：
TRANSLATIONAL ANDROLOGY AND UROLOGY | 2024年 / 13卷 / 03期
关键词：
Screening; prostate-specific antigen (PSA); prostate cancer (PCa); RISK;
D O I：
10.21037/tau-23-606
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
引用
收藏
页码：473 / 475
页数：3
相关论文
共 50 条
  • [1] Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer
    Buzzoni, Carlotta
    Auvinen, Anssi
    Roobol, Monique J.
    Carlsson, Sigrid
    Moss, Sue M.
    Puliti, Donella
    de Koning, Harry J.
    Bangma, Chris H.
    Denis, Louis J.
    Kwiatkowski, Maciej
    Lujan, Marcos
    Nelen, Vera
    Paez, Alvaro
    Randazzo, Marco
    Rebillard, Xavier
    Tammela, Teuvo L. J.
    Villers, Arnauld
    Hugosson, Jonas
    Schroder, Fritz H.
    Zappa, Marco
    EUROPEAN UROLOGY, 2015, 68 (05) : 885 - 890
  • [2] Prostate-specific antigen change in the European Randomized Study of screening for prostate cancer, section Rotterdam
    Raaijmakers, R
    Wildhagen, MF
    Ito, K
    Pàez, A
    De Vries, SH
    Roobol, MJ
    Schröder, FH
    UROLOGY, 2004, 63 (02) : 316 - 320
  • [3] On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer
    Bangma, Chris H.
    van Schaik, Ron H.
    Blijenberg, Bert G.
    Roobol, Monique J.
    Lilja, Hans
    Stenman, Ulf-Hakan
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (17) : 3109 - 3119
  • [4] Is Prostate-Specific Antigen Velocity Selective for Clinically Significant Prostate Cancer in Screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam)
    Wolters, Tineke
    Roobol, Monique J.
    Bangma, Chris H.
    Schroder, Fritz H.
    EUROPEAN UROLOGY, 2009, 55 (02) : 385 - 393
  • [5] Lead times and overdetection due to prostate-specific antigen screening:: Estimates from the European randomized study of screening for prostate cancer
    Draisma, G
    Boer, R
    Otto, SJ
    van der Cruijsen, IW
    Damhuis, RAM
    Schröder, FH
    de Koning, HJ
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (12) : 868 - 878
  • [6] Prostate-Specific Antigen Screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer-Rotterdam
    Wever, Elisabeth M.
    Draisma, Gerrit
    Heijnsdijk, Eveline A. M.
    Roobol, Monique J.
    Boer, Rob
    Otto, Suzie J.
    de Koning, Harry J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (05): : 352 - 355
  • [7] Use of Baseline Prostate-Specific Antigen Measurements to Personalize Prostate Cancer Screening
    Loeb, Stacy
    EUROPEAN UROLOGY, 2012, 61 (05) : 875 - 876
  • [8] Prostate-specific antigen and screening for prostate cancer
    Han, M
    Gann, PH
    Catalona, WJ
    MEDICAL CLINICS OF NORTH AMERICA, 2004, 88 (02) : 245 - +
  • [9] Prostate-specific antigen for prostate cancer screening
    不详
    BJU INTERNATIONAL, 2023, 131 (03) : 266 - 266
  • [10] Screening for Prostate Cancer with Prostate-specific Antigen
    Al-Monajjed, Rouvier
    Albers, Peter
    Hadaschik, Boris
    EUROPEAN UROLOGY OPEN SCIENCE, 2025, 74 : 71 - 72
12345